The drug-store chain is said to be in talks with Evolent, according to sources close to the matter who asked Bloomberg not to be identified. There is no certainty that Walgreens will go ahead with an offer to buy.
Evolent Health provides partnerships between healthcare providers and health plans and seeks to help providers transition to a value-based care model. It also works with insurance companies to cut costs and give guidance to physicians to achieve optimal care.
For Walgreens, the acquisition could diversify its portfolio through the technology-based platform and give access to relationships with payers.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
